Companies / United Kingdom
GSK Stung By Massive US Tax Payout
September 2006 | Legal NewsDemonstrating the power of US regulators, UK firm GlaxoSmithKline (GSK) has agreed to pay US$3.1bn to settle a tax dispute with the US government that was due to go to court next year. The settlement is the largest single payment made to the Internal Revenue Service (IRS) to resolve a taxation
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
